2 August 2024 · 1 min read
This is a fascinating development: Microsoft now formally lists OpenAI as a competitor, despite h...
Microsoft now formally lists OpenAI as a competitor, despite having invested $13 billion into the company — a move that may be tied to SearchGPT or antitrust optics. The strategic manoeuvres around these massive LLM-race investments are captivating.
This is a fascinating development: Microsoft now formally lists OpenAI as a competitor, despite having invested $13 billion into the company. This shift might be related to OpenAI's recent announcement of SearchGPT, or it could be a move to appease antitrust regulators.
The strategic manoeuvres around these massive investments in the LLM race are captivating. It might even make for an intriguing future movie—perhaps starring Rami Malek as Sam Altman?
Read more about it here: Microsoft Says OpenAI Is Now a Competitor in AI and Search
Related insights
23 Jun 2026
Pharma asked what frontier AI can build. Novo learned what it can take.
5 May 2026
Three things I watch when reading any pharma AI announcement in 2026
23 Mar 2026
Verily just raised $300M and, more importantly, ended Alphabet’s controlling stake.
19 Feb 2026
Clinical LLM benchmarks: why SNOMED CT mapping is a real-world test